IFNA1 and systemic lupus erythematosus: We assessed whether having pre-existing anti-IFNα autoantibodies was associated with COVID-19 infection in SLE patients.<h4>Methods</h4>Patients with SLE who developed COVID-19 between April 1<sup>st</sup> to October 1<sup>st</sup>, 2020 were studied.